IM Cannabis Corp. has seen a notable shift in its shareholder landscape with a recent filing by L.I.A. Pure Capital Ltd. The updated Schedule 13G/A indicates that L.I.A. Pure Capital now holds 96,864 shares, representing approximately 4.99% of the total outstanding shares of IM Cannabis. This change is significant as it reflects increasing interest and investment in the medicinal chemicals and botanical products sector.

Background

IM Cannabis Corp. is a key player in the medicinal chemicals and botanical products industry, identified under SIC code 2833. The company is publicly traded on the Nasdaq under the ticker symbol IMCC. Recent filings include a Schedule 13G and a Form 6-K, both dated November 13, 2026, indicating ongoing engagement with investors and regulatory bodies.

What the Filing Says

The Schedule 13G/A filing, dated November 13, 2026, reveals that L.I.A. Pure Capital Ltd. beneficially owns 96,864 shares of IM Cannabis. The filing states, "*Percentage calculated based on 1,844,162 common shares, no par value per share..." This indicates a strategic positioning by L.I.A. Pure Capital as they navigate the evolving landscape of the cannabis industry.

Impact

This increase in ownership may influence future decisions at IM Cannabis, as L.I.A. Pure Capital is now a significant stakeholder. The filing also highlights the competitive nature of the medicinal chemicals and botanical products sector, where investor interest can lead to shifts in company strategy and market positioning.

What's Next

The filing does not say what happens next.